Princeton Global Asset Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6K | Hold |
822
| – | – | 0.01% | 375 |
|
|
2025
Q1 | $31.8K | Sell |
822
-533
| -39% | -$20.6K | 0.01% | 346 |
|
|
2024
Q4 | $45.8K | Hold |
1,355
| – | – | 0.01% | 330 |
|
|
2024
Q3 | $55.4K | Sell |
1,355
-160
| -11% | -$6.54K | 0.01% | 304 |
|
|
2024
Q2 | $58.3K | Hold |
1,515
| – | – | 0.01% | 272 |
|
|
2024
Q1 | $64.9K | Hold |
1,515
| – | – | 0.02% | 232 |
|
|
2023
Q4 | $56.1K | Buy |
1,515
+533
| +54% | +$19.8K | 0.01% | 251 |
|
|
2023
Q3 | $35.6K | Hold |
982
| – | – | 0.01% | 280 |
|
|
2023
Q2 | $35K | Hold |
982
| – | – | 0.01% | 285 |
|
|
2023
Q1 | $34.9K | Buy |
982
+62
| +7% | +$2.21K | 0.01% | 288 |
|
|
2022
Q4 | $32K | Hold |
920
| – | – | 0.01% | 280 |
|
|
2022
Q3 | $27K | Hold |
920
| – | – | 0.01% | 290 |
|
|
2022
Q2 | $50K | Hold |
920
| – | – | 0.02% | 255 |
|
|
2022
Q1 | $50K | Hold |
920
| – | – | 0.01% | 266 |
|
|
2021
Q4 | $51K | Hold |
920
| – | – | 0.01% | 252 |
|
|
2021
Q3 | $44K | Sell |
920
-612
| -40% | -$29.3K | 0.01% | 267 |
|
|
2021
Q2 | $76K | Buy |
1,532
+640
| +72% | +$31.7K | 0.02% | 224 |
|
|
2021
Q1 | $40K | Hold |
892
| – | – | 0.01% | 259 |
|
|
2020
Q4 | $41K | Hold |
892
| – | – | 0.01% | 259 |
|
|
2020
Q3 | $42K | Hold |
892
| – | – | 0.02% | 227 |
|
|
2020
Q2 | $45K | Buy |
892
+640
| +254% | +$32.3K | 0.01% | 260 |
|
|
2020
Q1 | $12K | Sell |
252
-374
| -60% | -$17.8K | 0.01% | 374 |
|
|
2019
Q4 | $37 | Buy |
626
+374
| +148% | +$22 | 0.02% | 266 |
|
|
2019
Q3 | $14K | Sell |
252
-308
| -55% | -$17.1K | 0.01% | 287 |
|
|
2019
Q2 | $28K | Sell |
560
-160
| -22% | -$8K | 0.02% | 264 |
|
|
2019
Q1 | $37K | Buy |
+720
| New | +$37K | 0.03% | 213 |
|